Ken Griffin Beyond Air, Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Beyond Air, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 20,400 shares of XAIR stock, worth $5,916. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,400
Previous 20,000
2.0%
Holding current value
$5,916
Previous $7,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding XAIR
# of Institutions
50Shares Held
20.4MCall Options Held
31.2KPut Options Held
2.7K-
Alyeska Investment Group, L.P. Chicago, IL7.14MShares$2.07 Million0.01% of portfolio
-
Balyasny Asset Management LLC Chicago, IL3.33MShares$966,9780.0% of portfolio
-
Lasry Marc New York, NY2.79MShares$809,77612.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$366,7090.0% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny1MShares$290,0000.01% of portfolio
About Beyond Air, Inc.
- Ticker XAIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 29,888,000
- Market Cap $8.67M
- Description
- Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...